Storyline
FDA approves higher dose of Wegovy using priority review voucher
The FDA has approved a new higher dose (7.2 mg) of Novo Nordisk's Wegovy (semaglutide) injection for weight loss and long-term maintenance in certain adults.
Evidence locked
Today's free sample is only available for the edition's flagship storyline.
Evidence preview
- FDA press release on higher dose Wegovy approvalfda.gov
- FDA approves higher Wegovy dose via 4th priority voucherpharmaphorum
- Still basking in the afterglow of its Wegovy pill launch earlier this year, Novo has achieved another victory as it s...Fierce Pharma (All)
- Novo uses FDA voucher to win speedy approval of higher-dose WegovyBioPharma Dive